샘플 요청 목록

 카트 문의
시장보고서
상품코드
1449396

치루 치료 시장 점유율, 규모, 동향, 산업 분석 보고서 : 약물 유형별, 치료 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2032년)

Anal Fistula Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Anticholinergic, Proton-Pump Inhibitors, H2 Blockers, Antidiarrheals); By Treatment Type; By Application, By End Use, By Region, & Segment Forecasts, 2024-2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 연구에 따르면, 세계 치루 치료 시장 규모는 2032년까지 413억 4,000만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

치루 치료 시장은 전 세계적으로 치질 유병률이 증가함에 따라 성장을 경험하고 있습니다. 염증성 장 질환은 주요 원인으로, 특정 원인 없이 소화관(GI)의 지속적인 만성 염증을 유발하는 주요 원인입니다. 장루 치료 분야의 매출 성장은 제품 개발의 발전, 의약품 승인, 예측 기간 동안 생물학적 제제 및 바이오시밀러 의약품에 대한 선호도 증가 등의 요인에 의해 예측됩니다.

단일 세포 RNA 시퀀싱으로 대표되는 기술의 발전은 의료진이 항문루 치료를 관리하는 데 도움을 주고 있습니다. 크론병이나 궤양성 대장염으로 진단받은 환자의 장 검체에는 단일세포 RNA 시퀀싱이나 매스 사이토메트리와 같은 고차원 기술이 적용되고 있습니다. 단일 세포 RNA 시퀀싱 분석의 활용은 혁신적인 치료 전략 탐색, 개별 약물 맞춤화, 질병 예방 등 질병의 분자적 기초를 이해하는 데 있어 다양한 이점을 제공합니다.

유전적 소인, 환경적 요인, 크론병과 종종 연관된 면역 체계의 조절 장애 등 여러 요인이 치루 치료 시장의 유병률 증가에 기여하고 있습니다. 궤양성 대장염과 크론병 진단을 받은 환자의 상당수가 가족력이 있는 것으로 나타났습니다. 예를 들어, 홉킨스 메디슨(Hopkins Medicine)의 조사에 따르면, 크론병 환자의 약 10-15%는 크론병에 걸린 친척이 있는 것으로 나타났습니다. 마찬가지로 궤양성 대장염 진단을 받은 환자의 약 5-7%가 가족력이 있는 것으로 나타났습니다.

의료비 절감을 위해 업계 주요 기업들이 시행하고 있는 상환 전략은 효과적인 치료 옵션에 대한 환자들의 긍정적인 인식을 촉진할 것으로 예상됩니다. 장루 치료에 대한 투자 증가는 특히 의사들이 중등도에서 중증의 장루를 관리하기 위해 이러한 약물을 처방하는 것이 일반적이기 때문에 큰 투자 수익률(ROI)을 가져다 줄 것으로 예상됩니다. 또한, 항유착 분자, 특히 인테그린 길항제의 개발은 항문 누공에 대처할 수 있는 유망한 길을 보여주고 있습니다. 이러한 분자는 유착 형성에 관여하는 분자 메커니즘을 표적으로 삼아 누공의 재발을 줄이고 환자의 결과를 개선할 수 있습니다.

치루 치료 시장 보고서 하이라이트

2023년에는 수술 분야가 가장 큰 시장 점유율을 차지했으며, 특히 누공 수술과 같이 항문 누공에 대한 대응책으로 환자들에게 권장되고 선호되는 접근법이 등장하면서 수술 분야가 가장 큰 시장 점유율을 차지했습니다.

병원 부문은 수술실과 진단 능력을 포함한 첨단 의료 인프라를 갖춘 전문 진료과와 시설로 인해 예측 기간 동안 가장 빠른 CAGR을 기록할 것으로 예상됩니다.

북미 지역은 잘 갖춰진 병원, 진료소, 전문 의료 시설을 갖춘 첨단 의료 인프라로 인해 2023년 가장 큰 시장 점유율을 차지했습니다. 최첨단 진단 및 치료 자원을 이용할 수 있는 것은 효과적이고 종합적인 치질 관리에 기여합니다.

아시아태평양은 장 질환을 앓고 있는 인구가 많기 때문에 예측 기간 동안 가장 빠른 CAGR을 기록할 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 조사 방법

제4장 세계의 치루 치료 시장에 관한 인사이트

  • 치루 치료 - 업계 현황
  • 치루 치료 시장 역학
    • 성장 촉진요인과 기회
      • 장질환 발생률 증가
      • 치료 기술 진보
    • 성장 억제요인과 과제
      • 고액의 치료비
  • PESTLE 분석
  • 치루 치료 업계 동향
  • 밸류체인 분석
  • COVID-19 감염증의 영향 분석

제5장 세계의 치루 치료 시장, 약제 종류별

  • 주요 조사 결과
  • 소개
  • 항콜린 작용
  • 양성자 펌프 억제제
  • H2 차단제
  • 지사제

제6장 세계의 치루 치료 시장, 용도별

  • 주요 조사 결과
  • 소개
  • 괄약근간루
  • 경괄약근루
  • 괄약근상루
  • 기타

제7장 세계의 치루 치료 시장, 최종사용별

  • 주요 조사 결과
  • 소개
  • 병원
  • 외래 수술 센터
  • 기타

제8장 세계의 치루 치료 시장, 치료 유형별

  • 주요 조사 결과
  • 소개
  • 외과적
  • 비외과적

제9장 세계의 치루 치료 시장, 지역별

  • 주요 조사 결과
  • 소개
    • 치루 치료 시장 평가, 지역별, 2019-2032년
  • 치루 치료 시장 - 북미
    • 북미 : 치루 치료 시장, 의약품 유형별, 2019-2032년
    • 북미 : 치루 치료 시장, 치료 유형별, 2019-2032년
    • 북미 : 치루 치료 시장, 용도별, 2019-2032년
    • 북미 : 치루 치료 시장, 최종사용별, 2019-2032년
    • 치루 치료 시장 - 미국
    • 치루 치료 시장 - 캐나다
  • 치루 치료 시장 - 유럽
    • 유럽 : 치루 치료 시장, 약제 유형별, 2019-2032년
    • 유럽 : 치루 치료 시장, 치료 유형별, 2019-2032년
    • 유럽 : 치루 치료 시장, 용도별, 2019-2032년
    • 유럽 : 치루 치료 시장, 최종사용별, 2019-2032년
    • 치루 치료 시장 - 영국
    • 치루 치료 시장 - 프랑스
    • 치루 치료 시장 - 독일
    • 치루 치료 시장 - 이탈리아
    • 치루 치료 시장 - 스페인
    • 치루 치료 시장 - 네델란드
    • 치루 치료 시장 - 러시아
  • 치루 치료 시장 - 아시아태평양
    • 아시아태평양 : 치루 치료 시장, 약제 유형별, 2019-2032년
    • 아시아태평양 : 치루 치료 시장, 치료 유형별, 2019-2032년
    • 아시아태평양 : 치루 치료 시장, 용도별, 2019-2032년
    • 아시아태평양 : 치루 치료 시장, 최종사용별, 2019-2032년
    • 치루 치료 시장 - 중국
    • 치루 치료 시장 - 인도
    • 치루 치료 시장 - 일본
    • 치루 치료 시장 - 말레이시아
    • 치루 치료 시장 - 인도네시아
    • 치루 치료 시장 - 한국
  • 치루 치료 시장 - 중동 및 아프리카
    • 중동 및 아프리카 : 치루 치료 시장, 약제 유형별, 2019-2032년
    • 중동 및 아프리카 : 치루 치료 시장, 치료 유형별, 2019-2032년
    • 중동 및 아프리카 : 치루 치료 시장, 용도별, 2019-2032년
    • 중동 및 아프리카 : 치루 치료 시장, 최종사용별, 2019-2032년
    • 치루 치료 시장 - 사우디아라비아
    • 치루 치료 시장 - 남아프리카공화국
    • 치루 치료 시장 - 이스라엘
    • 치루 치료 시장 - 아랍에미리트
  • 치루 치료 시장 - 라틴아메리카
    • 라틴아메리카 : 치루 치료 시장, 약제 유형별, 2019-2032년
    • 라틴아메리카 : 치루 치료 시장, 치료 유형별, 2019-2032년
    • 라틴아메리카 : 치루 치료 시장, 용도별, 2019-2032년
    • 라틴아메리카 : 치루 치료 시장, 최종사용별, 2019-2032년
    • 치루 치료 시장 - 멕시코
    • 치루 치료 시장 - 브라질
    • 치루 치료 시장 - 아르헨티나

제10장 경쟁 상황

  • 확장과 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제11장 기업 개요

  • Angiplast Pvt. Ltd.
  • Avante Health Solutions
  • Biolitec AG
  • Cliniva Healthcare
  • Cook Medical
  • Gulmaher Surgico
  • Integra LifeSciences
  • KARL STORZ
  • Medtronic plc
  • Novo Surgical Inc.
  • Signum Surgical
  • Sklar Surgical Instruments
ksm 24.04.01

The global anal fistula treatment market size is expected to reach USD 41.34 billion by 2032, according to a new study by Polaris Market Research. The report "Anal Fistula Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Anticholinergic, Proton-Pump Inhibitors, H2 Blockers, Antidiarrheals); By Treatment Type; By Application, By End Use, By Region, And Segment Forecasts, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The anal fistula treatment market is experiencing growth propelled by the global increase in the prevalence of this condition. Inflammatory bowel diseases are a primary cause, leading to persistent chronic inflammation of the gastrointestinal (GI) tract without identifiable triggers. Revenue expansion in the intestinal fistula treatment sector is anticipated due to factors like advancements in product development, drug approvals, and a growing preference for biologic and biosimilar medications throughout the forecast period.

Advancements in technology, exemplified by single-cell RNA sequencing, are aiding healthcare practitioners in managing anal fistula treatment. High-dimensional techniques like single-cell RNA sequencing and mass cytometry have been applied to intestinal specimens obtained from individuals diagnosed with Crohn's disease or ulcerative colitis. The utilization of single-cell RNA sequencing analysis offers various advantages in comprehending the molecular underpinnings of the disease, including the exploration of innovative therapeutic strategies, customization of individual medications, and disease prevention.

Multiple factors contribute to the escalating prevalence of the anal fistula treatment market, including genetic predisposition, environmental triggers, and immune system dysregulation, often associated with the Crohn's Disease. A significant proportion of patients diagnosed with ulcerative colitis or Crohn's disease exhibit a familial history of the condition. For instance, research conducted by Hopkins Medicine indicates that approximately 10 to 15% of individuals with Crohn's disease have relatives affected by the disorder. Similarly, around 5 to 7% of patients diagnosed with ulcerative colitis have a familial history of the condition.

Reimbursement strategies implemented by key industry players to mitigate healthcare costs are expected to foster favorable patient perceptions regarding effective treatment options. Increased investments in intestinal fistula treatment are also projected to yield significant returns on investment (ROI), particularly as physicians commonly prescribe these medications for managing moderate to severe intestinal fistula cases. Furthermore, the development of anti-adhesion molecules, particularly integrin antagonists, presents a promising avenue for addressing anal fistula. These molecules target the molecular mechanisms involved in adhesion formation, potentially reducing the recurrence of fistulas and improving patient outcomes.

Anal Fistula Treatment Market Report Highlights

In 2023, the surgical segment accounted for the largest market share due to interventions, particularly fistula surgery, that emerged as the recommended and preferred approach for addressing anal fistulas among patients.

The hospital segment is expected to witness the fastest CAGR during the forecast period due to specialized departments and facilities equipped with advanced medical infrastructure, including surgical units and diagnostic capabilities.

North America dominated the largest market share in 2023, due to advanced healthcare infrastructure with well-equipped hospitals, clinics, and specialized healthcare facilities. The availability of state-of-the-art diagnostic and treatment resources contributes to effective and comprehensive anal fistula management.

Asia Pacific region is expected to witness the fastest CAGR during the forecast period on account of the presence of a huge population suffering from intestinal disorders.

The global players include Avante Health, Biolitec, Cliniva Healthcare, Cook Medical, Gulmaher Surgico, KARL STORZ, Novo Surgical, and more.

Polaris Market Research has segmented the anal fistula treatment market report based on drug type, treatment type, application, end use, and region:

Anal Fistula Treatment, Durg Type Outlook (Revenue - USD Billion, 2019- 2032)

  • Anticholinergic
  • Proton-Pump Inhibitors
  • H2 Blockers
  • Antidiarrheals

Anal Fistula Treatment, Treatment Type Outlook (Revenue - USD Billion, 2019- 2032)

  • Surgical
  • Non-Surgical

Anal Fistula Treatment, Application Outlook (Revenue - USD Billion, 2019- 2032)

  • Intersphincteric Fistula
  • Transsphincteric Fistula
  • Suprasphincteric Fistula
  • Others

Anal Fistula Treatment, End Use Outlook (Revenue - USD Billion, 2019- 2032)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Anal Fistula Treatment, Regional Outlook (Revenue - USD Billion, 2019- 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1.Introduction

  • 1.1.Report Description
    • 1.1.1.Objectives of the Study
    • 1.1.2.Market Scope
    • 1.1.3.Assumptions
  • 1.2.Stakeholders

2.Executive Summary

  • 2.1.Market Highlights

3.Research Methodology

  • 3.1.Overview
    • 3.1.1.Data Mining
  • 3.2.Data Sources
    • 3.2.1.Primary Sources
    • 3.2.2.Secondary Sources

4.Global Anal Fistula Treatment Market Insights

  • 4.1.Anal Fistula Treatment - Industry Snapshot
  • 4.2.Anal Fistula Treatment Market Dynamics
    • 4.2.1.Drivers and Opportunities
      • 4.2.1.1.Rising incidence of bowel diseases
      • 4.2.1.2.Advancements in Treatment Technologies
    • 4.2.2.Restraints and Challenges
      • 4.2.2.1.High cost of treatment
  • 4.3.Porter's Five Forces Analysis
    • 4.3.1.Bargaining Power of Suppliers (Moderate)
    • 4.3.2.Threats of New Entrants: (Low)
    • 4.3.3.Bargaining Power of Buyers (Moderate)
    • 4.3.4.Threat of Substitute (Moderate)
    • 4.3.5.Rivalry among existing firms (High)
  • 4.4.PESTLE Analysis
  • 4.5.Anal Fistula Treatment Industry Trends
  • 4.6.Value Chain Analysis
  • 4.7.COVID-19 Impact Analysis

5.Global Anal Fistula Treatment Market, by Drug Type

  • 5.1.Key Findings
  • 5.2.Introduction
    • 5.2.1.Global Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
  • 5.3.Anticholinergic
    • 5.3.1.Global Anal Fistula Treatment Market, by Anticholinergic, by Region, 2019-2032 (USD Billion)
  • 5.4.Proton-Pump Inhibitors
    • 5.4.1.Global Anal Fistula Treatment Market, by Proton-Pump Inhibitors, by Region, 2019-2032 (USD Billion)
  • 5.5.H2 Blockers
    • 5.5.1.Global Anal Fistula Treatment Market, by H2 Blockers, by Region, 2019-2032 (USD Billion)
  • 5.6.Antidiarrheals
    • 5.6.1.Global Anal Fistula Treatment Market, by Antidiarrheals, by Region, 2019-2032 (USD Billion)

6.Global Anal Fistula Treatment Market, by Application

  • 6.1.Key Findings
  • 6.2.Introduction
    • 6.2.1.Global Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
  • 6.3.Intersphincteric Fistula
    • 6.3.1.Global Anal Fistula Treatment Market, by Intersphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.4.Transsphincteric Fistula
    • 6.4.1.Global Anal Fistula Treatment Market, by Transsphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.5.Suprasphincteric Fistula
    • 6.5.1.Global Anal Fistula Treatment Market, by Suprasphincteric Fistula, by Region, 2019-2032 (USD Billion)
  • 6.6.Others
    • 6.6.1.Global Anal Fistula Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

7.Global Anal Fistula Treatment Market, by End-use

  • 7.1.Key Findings
  • 7.2.Introduction
    • 7.2.1.Global Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 7.3.Hospitals
    • 7.3.1.Global Anal Fistula Treatment Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 7.4.Ambulatory Surgical Centers
    • 7.4.1.Global Anal Fistula Treatment Market, by Ambulatory Surgical Centers, by Region, 2019-2032 (USD Billion)
  • 7.5.Others
    • 7.5.1.Global Anal Fistula Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

8.Global Anal Fistula Treatment Market, by Treatment Type

  • 8.1.Key Findings
  • 8.2.Introduction
    • 8.2.1.Global Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • 8.3.Surgical
    • 8.3.1.Global Anal Fistula Treatment Market, by Surgical, by Region, 2019-2032 (USD Billion)
  • 8.4.Non-Surgical
    • 8.4.1.Global Anal Fistula Treatment Market, by Non-Surgical, by Region, 2019-2032 (USD Billion)

9.Global Anal Fistula Treatment Market, by Geography

  • 9.1.Key findings
  • 9.2.Introduction
    • 9.2.1.Anal Fistula Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3.Anal Fistula Treatment Market - North America
    • 9.3.1.North America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.3.2.North America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.3.3.North America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.3.4.North America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.3.5.Anal Fistula Treatment Market - U.S.
      • 9.3.5.1.U.S.: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.3.5.2.U.S.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.3.5.3.U.S.: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.3.5.4.U.S.: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.3.6.Anal Fistula Treatment Market - Canada
      • 9.3.6.1.Canada: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.3.6.2.Canada: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.3.6.3.Canada: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.3.6.4.Canada: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.4.Anal Fistula Treatment Market - Europe
    • 9.4.1.Europe: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.4.2.Europe: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.4.3.Europe: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.4.4.Europe: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.5.Anal Fistula Treatment Market - UK
      • 9.4.5.1.UK: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.5.2.UK: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.5.3.UK: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.5.4.UK: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.6.Anal Fistula Treatment Market - France
      • 9.4.6.1.France: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.6.2.France: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.6.3.France: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.6.4.France: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.7.Anal Fistula Treatment Market - Germany
      • 9.4.7.1.Germany: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.7.2.Germany: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.7.3.Germany: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.7.4.Germany: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.8.Anal Fistula Treatment Market - Italy
      • 9.4.8.1.Italy: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.8.2.Italy: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.8.3.Italy: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.8.4.Italy: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.9.Anal Fistula Treatment Market - Spain
      • 9.4.9.1.Spain: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.9.2.Spain: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.9.3.Spain: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.9.4.Spain: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.10.Anal Fistula Treatment Market - Netherlands
      • 9.4.10.1.Netherlands: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.10.2.Netherlands: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.10.3.Netherlands: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.10.4.Netherlands: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.4.11.Anal Fistula Treatment Market - Russia
      • 9.4.11.1.Russia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.4.11.2.Russia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.4.11.3.Russia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.4.11.4.Russia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.5.Anal Fistula Treatment Market - Asia Pacific
    • 9.5.1.Asia Pacific: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.5.2.Asia Pacific: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.5.3.Asia Pacific: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.5.4.Asia Pacific: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.5.Anal Fistula Treatment Market - China
      • 9.5.5.1.China: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.5.2.China.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.5.3.China: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.5.4.China: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.6.Anal Fistula Treatment Market - India
      • 9.5.6.1.India: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.6.2.India.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.6.3.India: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.6.4.India: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.7.Anal Fistula Treatment Market - Japan
      • 9.5.7.1.Japan: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.7.2.Japan.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.7.3.Japan: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.7.4.Japan: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.8.Anal Fistula Treatment Market - Malaysia
      • 9.5.8.1.Malaysia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.8.2.Malaysia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.8.3.Malaysia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.8.4.Malaysia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.9.Anal Fistula Treatment Market - Indonesia
      • 9.5.9.1.Indonesia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.9.2.Indonesia.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.9.3.Indonesia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.9.4.Indonesia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.5.10.Anal Fistula Treatment Market - South Korea
      • 9.5.10.1.South Korea: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.5.10.2.South Korea.: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.5.10.3.South Korea: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.5.10.4.South Korea: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.6.Anal Fistula Treatment Market - Middle East & Africa
    • 9.6.1.Middle East & Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.6.2.Middle East & Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.6.3.Middle East & Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.6.4.Middle East & Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.5.Anal Fistula Treatment Market - Saudi Arabia
      • 9.6.5.1.Saudi Arabia: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.5.2.Saudi Arabia: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.5.3.Saudi Arabia: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.5.4.Saudi Arabia: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.6.Anal Fistula Treatment Market - South Africa
      • 9.6.6.1.South Africa: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.6.2.South Africa: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.6.3.South Africa: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.6.4.South Africa: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.7.Anal Fistula Treatment Market - Israel
      • 9.6.7.1.Israel: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.7.2.Israel: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.7.3.Israel: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.7.4.Israel: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.6.8.Anal Fistula Treatment Market - UAE
      • 9.6.8.1.UAE: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.6.8.2.UAE: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.6.8.3.UAE: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.6.8.4.UAE: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
  • 9.7.Anal Fistula Treatment Market - Latin America
    • 9.7.1.Latin America: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
    • 9.7.2.Latin America: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 9.7.3.Latin America: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
    • 9.7.4.Latin America: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.5.Anal Fistula Treatment Market - Mexico
      • 9.7.5.1.Mexico: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.5.2.Mexico: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.5.3.Mexico: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.5.4.Mexico: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.6.Anal Fistula Treatment Market - Brazil
      • 9.7.6.1.Brazil: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.6.2.Brazil: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.6.3.Brazil: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.6.4.Brazil: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)
    • 9.7.7.Anal Fistula Treatment Market - Argentina
      • 9.7.7.1.Argentina: Anal Fistula Treatment Market, by Drug Type, 2019-2032 (USD Billion)
      • 9.7.7.2.Argentina: Anal Fistula Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
      • 9.7.7.3.Argentina: Anal Fistula Treatment Market, by Application, 2019-2032 (USD Billion)
      • 9.7.7.4.Argentina: Anal Fistula Treatment Market, by End-use, 2019-2032 (USD Billion)

10.Competitive Landscape

  • 10.1.Expansion and Acquisition Analysis
    • 10.1.1.Expansion
    • 10.1.2.Acquisitions
  • 10.2.Partnerships/Collaborations/Agreements/Exhibitions

11.Company Profiles

  • 11.1.Angiplast Pvt. Ltd.
    • 11.1.1.Company Overview
    • 11.1.2.Financial Performance
    • 11.1.3.Product Benchmarking
    • 11.1.4.Recent Development
  • 11.2.Avante Health Solutions
    • 11.2.1.Company Overview
    • 11.2.2.Financial Performance
    • 11.2.3.Product Benchmarking
    • 11.2.4.Recent Development
  • 11.3.Biolitec AG
    • 11.3.1.Company Overview
    • 11.3.2.Financial Performance
    • 11.3.3.Product Benchmarking
    • 11.3.4.Recent Development
  • 11.4.Cliniva Healthcare
    • 11.4.1.Company Overview
    • 11.4.2.Financial Performance
    • 11.4.3.Product Benchmarking
    • 11.4.4.Recent Development
  • 11.5.Cook Medical
    • 11.5.1.Company Overview
    • 11.5.2.Financial Performance
    • 11.5.3.Product Benchmarking
    • 11.5.4.Recent Development
  • 11.6.Gulmaher Surgico
    • 11.6.1.Company Overview
    • 11.6.2.Financial Performance
    • 11.6.3.Product Benchmarking
    • 11.6.4.Recent Development
  • 11.7.Integra LifeSciences
    • 11.7.1.Company Overview
    • 11.7.2.Financial Performance
    • 11.7.3.Product Benchmarking
    • 11.7.4.Recent Development
  • 11.8.KARL STORZ
    • 11.8.1.Company Overview
    • 11.8.2.Financial Performance
    • 11.8.3.Product Benchmarking
    • 11.8.4.Recent Development
  • 11.9.Medtronic plc
    • 11.9.1.Company Overview
    • 11.9.2.Financial Performance
    • 11.9.3.Product Benchmarking
    • 11.9.4.Recent Development
  • 11.10.Novo Surgical Inc.
    • 11.10.1.Company Overview
    • 11.10.2.Financial Performance
    • 11.10.3.Product Benchmarking
    • 11.10.4.Recent Development
  • 11.11.Signum Surgical
    • 11.11.1.Company Overview
    • 11.11.2.Financial Performance
    • 11.11.3.Product Benchmarking
    • 11.11.4.Recent Development
  • 11.12.Sklar Surgical Instruments
    • 11.12.1.Company Overview
    • 11.12.2.Financial Performance
    • 11.12.3.Product Benchmarking
    • 11.12.4.Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제